October 4, 2005

The invention relates to fluorobenzamide derivatives of the formula ##STR1## wherein R.sup.1, R.sup.2, R.sup.3 R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as defined herein. =, The compounds of the invention are selective monoamine oxidase B inhibitors and therefore they are suitable for the treatment of diseases mediated by monoamine oxidase B, such as Alzheimer's disease or senile dementia.

45

October 4, 2005

10/456,641

June 6, 2003

514/522   514/616 514/622 558/392 558/415 564/155 564/171

A61K   31/166   (20060101)   A61K   31/16   (20060101)   A61K   31/275   (20060101)   A61K   31/277   (20060101)   A61K   31/165   (20060101)   A61P   25/16   (20060101)   A61P   25/18   (20060101)   A61P   25/00   (20060101)   A61P   25/22   (20060101)   A61P   25/02   (20060101)   A61P   25/24   (20060101)   A61P   25/28   (20060101)   A61P   25/30   (20060101)   A61P   25/32   (20060101)   A61P   25/34   (20060101)   A61P   3/04   (20060101)   A61P   3/00   (20060101)   C07C   231/00   (20060101)   C07C   237/06   (20060101)   C07C   233/83   (20060101)   C07C   235/00   (20060101)   C07C   235/50   (20060101)   C07C   237/00   (20060101)   C07C   235/48   (20060101)   C07C   233/69   (20060101)   C07C   253/00   (20060101)   C07C   255/24   (20060101)   C07C   253/30   (20060101)   C07C   255/29   (20060101)   C07C   233/00   (20060101)   C07C   255/00   (20060101)   C07C   233/65   (20060101)   C07C   255/55   (20060101)   C07C   255/44   (20060101)   A61P   43/00   (20060101)   C07C   231/02   (20060101)   C07C   231/14   (20060101)   C07C   231/16   (20060101)   C07B   53/00   (20060101)  

Jun 12, 2002 [EP] 02012484

564/155   564/171   558/392   558/415   514/616   514/622